Molecular genetic alterations in glioblastomas with oligodendroglial component

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Acta Neuropathologica

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s004010000258PMID 11355302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.

  1999cited by this paper
• The hPMS2 exon 5 mutation and malignant glioma. Case report.

  1999cited by this paper
• Progression as exemplified by human astrocytic tumors.

  1999cited by this paper
• Primary and secondary glioblastomas: from concept to clinical diagnosis.

  1999cited by this paper
• Molecular pathogenesis of malignant gliomas.

  1999cited by this paper
• Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas

  1999cited by this paper
• Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

  1999cited by this paper
• LONG SURVIVALS AND THERAPEUTIC RESPONSES IN HIGH-GRADE GLIOMAS WITH CHROMOSOME 1p LOSS THAT ARE NOT CLASSIC ANAPLASTIC OLIGODENDROGLIOMAS

  1999cited by this paper
• Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

  1999influential reference
• Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

  1999cited by this paper
• Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

  1998influential reference
• PTEN mutations in gliomas and glioneuronal tumors

  1998cited by this paper
• Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

  1998cited by this paper
• Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

  1998cited by this paper
• Tumors of the central nervous system.

  1998influential reference
• Molecular Genetic Evidence for Subtypes of Oligoastrocytomas

  1997cited by this paper
• Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.

  1996cited by this paper
• Recurrent gain of chromosome arm 7q in low‐grade astrocytic tumors studied by comparative genomic hybridization

  1996cited by this paper
• Analysis of p53 Mutation and Epidermal Growth Factor Receptor Amplification in Recurrent Gliomas with Malignant Progression

  1996cited by this paper
• Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.

  1996cited by this paper
• Treatment of malignant glioma in adults.

  1995cited by this paper
• The p53 gene and its role in human brain tumors

  1995cited by this paper
• Treatment of malignant glioma in adults

  1995cited by this paper
• Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and Oligoastrocytoma

  1995cited by this paper
• Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

  1994cited by this paper
• Molecular analysis of chromosomh 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors

  1994cited by this paper
• Deletion of p16 and p15 genes in brain tumors.

  1994cited by this paper
• TP53 alterations and clinical outcome in low grade astrocytomas

  1994cited by this paper
• CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

  1994cited by this paper
• Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

  1994cited by this paper
• Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.

  1994cited by this paper
• Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

  1993cited by this paper
• Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

  1993influential reference
• Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas

  1992cited by this paper
• Allelotype of human malignant astrocytoma.

  1990cited by this paper
• Response criteria for phase II studies of supratentorial malignant glioma.

  1990cited by this paper
• Effects of treatment on long‐term survivors with malignant astrocytomas

  1990influential reference
• A Laboratory manual

  1989cited by this paper
• Clonal genomic alterations in glioma malignancy stages.

  1988cited by this paper
• Patient age, histologic features, and length of survival in patients with glioblastoma multiforme

  1987cited by this paper

• Neuron-Like Lineage Differentiation Induced by Exogenous Neurexin-1 as a Potential Therapeutic Strategy for Glioma.

  2024cites this paper
• IDH1, ATRX, p53, and Ki67 Expression in Glioblastoma patients: Their Clinical and Prognostic Significance—A Prospective Study

  2024cites this paper
• Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma

  2022cites this paper
• Histopathology of Adult and Pediatric Glioblastoma

  2021cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• Hybrid Imaging for Tumors of the Brain

  2019cites this paper
• Overexpression of LACTB, a Mitochondrial Protein That Inhibits Proliferation and Invasion in Glioma Cells.

  2019cites this paper
• RBM17 controls apoptosis and proliferation to promote Glioma progression.

  2018cites this paper
• Glioblastoma and Glioblastoma with Oligodendroglial Component: a Histological and Prognostic Overview Runing Head: pathology and GBM and GBMO

  2018cites this paper
• Glioblastoma Multiforme: A clinico-pathological analysis

  2017cites this paper
• Integration of gene expression and methylation to unravel biological networks in glioblastoma patients

  2017cites this paper
• Epidermal growth factor receptor, vascular endothelial growth factor, mouse double minute 2 homolog, Ki 67, and p53 expression in glioblastoma: A survival analysis including the prognostic value of clinical, histopathological, and immunohistochemical parameters

  2017cites this paper
• Positive expression of KIF20A indicates poor prognosis of glioma patients

  2016cites this paper
• Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups

  2016cites this paper
• Diagnostic Applications of Nuclear Medicine: Brain Tumors

  2016cites this paper
• Gliomas - ReadingSample

  2016cites this paper
• Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system

  2016cites this paper
• Integration of Gene Expression Data and Methylation Reveals Genetic Networks for Glioblastoma

  2015cites this paper
• A multi-resolution textural approach to diagnostic neuropathology reporting

  2015cites this paper
• Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?

  2015cites this paper
• Genetic Analysis of a Case of Glioblastoma with Oligodendroglial Component Arising During the Progression of Diffuse Astrocytoma

  2015cites this paper
• A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.

  2015cites this paper
• Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components

  2015cites this paper
• Intraoperative diagnosis of glioblastomamultiforme with oligodendroglial and sarcomatous components

  2015cites this paper
• Prognostic Relevance of Histomolecular Classification of Diffuse Adult High‐Grade Gliomas with Necrosis

  2015cites this paper
• Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status1

  2014cites this paper
• Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

  2014cites this paper
• A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component

  2014cites this paper
• Immunohistochemical evaluation of O6‐methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma

  2014cites this paper
• Identification of differential splicing genes in gliomas using exon expression profiling

  2014cites this paper
• Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma

  2014cites this paper
• Clinicopathologic Characteristics of Brain Tumors are Associated with the Presence and Patterns of TP53 Mutations: Evidence from the IARC TP53 Database

  2014cites this paper
• MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1

  2014cites this paper
• Diagnosis and prognosis of brain tumors in clinical trials

  2013cites this paper
• Gliosarcoma arising from an oligodendroglioma (oligosarcoma).

  2013cites this paper
• Glioblastoma with Oligodendroglioma Component (GBM‐O): Molecular Genetic and Clinical Characteristics

  2013cites this paper
• Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.

  2013cites this paper
• Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma

  2013cites this paper
• Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature.

  2013cites this paper
• Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution

  2013cites this paper
• Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age

  2013cites this paper
• Pediatric glioblastoma with oligodendroglioma component: Aggressive clinical phenotype with distinct molecular characteristics

  2013cites this paper
• Clinical and histological characteristics of recurrent oligodendroglial tumors: comparison between primary and recurrent tumors in 18 cases

  2013cites this paper
• Success at Last: A Molecular Factor That Informs Treatment

  2013cites this paper
• Glioblastoma With Oligodendroglioma Component: A Review of Clinical, Morphologic, and Molecular Characteristics

  2013cites this paper
• Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas

  2012cites this paper
• Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors

  2012cites this paper
• Functional properties of the plasma membrane of human glioma initiating cells

  2012influential citation
• Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.

  2012cites this paper
• Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.

  2012cites this paper
• Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

  2012cites this paper
• 21 – Glioblastoma and malignant astrocytoma

  2012cites this paper
• The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.

  2012influential citation
• 3 – Classification and pathogenesis of brain tumors

  2012cites this paper
• Differenzierung und angiogenes Potenzial humaner mesenchymaler Stammzellen in Abhängigkeit von tumorkonditioniertem Medium des Glioblastoma multiforme

  2011cites this paper
• Diagnostic markers for glioblastoma.

  2011cites this paper
• Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status

  2011cites this paper
• Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO)

  2011cites this paper
• Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.

  2011cites this paper
• Expressionsanalyse von Notch 1, Notch 2 und Cyclin D1 in Gliomen

  2011cites this paper
• Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.

  2011cites this paper
• Review Diagnostic markers for glioblastoma

  2011cites this paper
• Pathology and Classification of Tumors of the Nervous System

  2010cites this paper
• Molecular markers in gliomas: impact for the clinician

  2010cites this paper
• Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.

  2010cites this paper
• Glioblastomes lioblastomes : facteurs pronostiques cliniques , radiologiques et biologiques lioblastoma : Clinical , radiological and biological prognostic factors

  2010cites this paper
• [Glioblastoma: clinical, radiological and biological prognostic factors].

  2010cites this paper
• Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic Subclassification

  2010influential citation
• Current concepts in the pathology and genetics of gliomas.

  2009cites this paper
• Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases

  2009cites this paper
• Molecular pathology of oligodendroglial tumors.

  2009cites this paper
• Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients

  2009influential citation
• Molekularzytogenetische Charakterisierung von Glioblastomen mit einer oligodendroglialen Komponente als Beitrag zur Einführung einer individuellen Diagnostik

  2008cites this paper
• The 2007 WHO Classification of Tumors of the Nervous System: Controversies in Surgical Neuropathology

  2008cites this paper
• Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component

  2008cites this paper
• Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis

  2008cites this paper
• A GBM by Any Other Name?

  2008cites this paper
• [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].

  2008cites this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cites this paper
• FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma

  2007cites this paper
• The 2007 WHO classification of tumours of the central nervous system

  2007cites this paper
• The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.

  2007cites this paper
• Long-term survival with glioblastoma multiforme.

  2007influential citation
• Statistical contributions to medical research in the South West Peninsula

  2007cites this paper
• Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors

  2007cites this paper
• Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.

  2006cites this paper
• Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

  2006influential citation
• Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma

  2006influential citation
• Kapitel 34 – Intrakranielle und spinale Tumoren

  2005cites this paper
• Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.

  2005cites this paper
• Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.

  2005cites this paper
• Research report Robustness of gene expression profiling in glioma specimen samplings and derived cell lines

  2005cites this paper
• Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.

  2005cites this paper
• Pathology and molecular genetics of astrocytic gliomas

  2004cites this paper
• [Oligodendroglial and neuronal component in glioblastomas: possible relation with prognosis].

  2004cites this paper
• Molecular Mechanisms Associated with Chromosomal and Microsatellite Instability in Sporadic Glioblastoma multiforme

  2004cites this paper
• Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

  2004cites this paper
• Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival

  2004cites this paper
• Molecular pathogenesis of oligodendroglial tumors

  2004cites this paper
• Correlation of in vitro infiltration with glioma histological type in organotypic brain slices

  2004influential citation